Article
Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status.
The British journal of surgery - 1 May 2017
Odisio B C, Yamashita S, Huang S Y, Harmoush S, Kopetz S E, Ahrar K, Shin Chun Y, Conrad C, Aloia T A, Gupta S, Hicks M E, Vauthey J-N
Abstract excerpt
BACKGROUND: Percutaneous ablation is a common treatment for colorectal liver metastasis (CLM). However, the effect of rat sarcoma viral oncogene homologue (RAS) mutation on outcome after ablation of CLMs is unclear. METHODS: Patients who underwent image-guided percutaneous ablation of CLMs from 2004 to 2015 and had known RAS mutation status were analysed. Patients were evaluated for local tumour progression as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.